iShares Russell Top 200
Eli Lilly’s 1Q17 Earnings: Strattera and Other Neuroscience Products
Strattera, a drug for attention-deficit hyperactivity disorder, reported a 4% increase in revenues to $196.2 million in 1Q17, compared to $188.1 million in 1Q16.
How Did DuPont’s Performance Materials Segment Perform in 2Q16?
For 2Q16, DuPont’s Performance Materials segment reported revenue of $1.33 billion, representing 18.9% of DuPont’s total revenue.